Patricia Ann Duffy

Array ( [id] => 4027814 [patent_doc_number] => 05883230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Multidomain hematopoiesis stimulators' [patent_app_type] => 1 [patent_app_number] => 8/658762 [patent_app_country] => US [patent_app_date] => 1996-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7546 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883230.pdf [firstpage_image] =>[orig_patent_app_number] => 658762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044497 [patent_doc_number] => 05912183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Peptide inhibitors of mitogenesis and motogenesis' [patent_app_type] => 1 [patent_app_number] => 8/654604 [patent_app_country] => US [patent_app_date] => 1996-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 39 [patent_no_of_words] => 16558 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912183.pdf [firstpage_image] =>[orig_patent_app_number] => 654604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062502 [patent_doc_number] => 06008001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Diagnosis of the susceptibility of contracting schizophrenia' [patent_app_type] => 1 [patent_app_number] => 8/637786 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2344 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008001.pdf [firstpage_image] =>[orig_patent_app_number] => 637786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 894010 [patent_doc_number] => 07341727 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-11 [patent_title] => 'M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same' [patent_app_type] => utility [patent_app_number] => 08/642712 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16206 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341727.pdf [firstpage_image] =>[orig_patent_app_number] => 08642712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757749 [patent_doc_number] => 05843695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Method for decomposing amyloid protein precursor and amyloid .beta.-protein' [patent_app_type] => 1 [patent_app_number] => 8/641774 [patent_app_country] => US [patent_app_date] => 1996-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 1570 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843695.pdf [firstpage_image] =>[orig_patent_app_number] => 641774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1229199 [patent_doc_number] => 06696557 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-24 [patent_title] => 'AL-2 neurotrophic factor nucleic acid' [patent_app_type] => B1 [patent_app_number] => 08/635130 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 8 [patent_no_of_words] => 36222 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696557.pdf [firstpage_image] =>[orig_patent_app_number] => 08635130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963593 [patent_doc_number] => 05885786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Methods for screening of substances for inhibition of multidrug resistance' [patent_app_type] => 1 [patent_app_number] => 8/636513 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 25983 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885786.pdf [firstpage_image] =>[orig_patent_app_number] => 636513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248654 [patent_doc_number] => 06221840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Intestinal trefoil proteins' [patent_app_type] => 1 [patent_app_number] => 8/631469 [patent_app_country] => US [patent_app_date] => 1996-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8953 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221840.pdf [firstpage_image] =>[orig_patent_app_number] => 631469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979693 [patent_doc_number] => 05948763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits' [patent_app_type] => 1 [patent_app_number] => 8/630645 [patent_app_country] => US [patent_app_date] => 1996-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 34 [patent_no_of_words] => 11802 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948763.pdf [firstpage_image] =>[orig_patent_app_number] => 630645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725047 [patent_doc_number] => 05672682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Conotoxin peptide PVIIA' [patent_app_type] => 1 [patent_app_number] => 8/619936 [patent_app_country] => US [patent_app_date] => 1996-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 16 [patent_no_of_words] => 7610 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672682.pdf [firstpage_image] =>[orig_patent_app_number] => 619936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406162 [patent_doc_number] => 06238892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Monoclonal antibodies directed against the microtubule-associated protein tau' [patent_app_type] => 1 [patent_app_number] => 8/617987 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9650 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238892.pdf [firstpage_image] =>[orig_patent_app_number] => 617987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933174 [patent_doc_number] => 05871712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Methods for detecting calpain activation and identifying calpain inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/592098 [patent_app_country] => US [patent_app_date] => 1996-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 25 [patent_no_of_words] => 7610 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871712.pdf [firstpage_image] =>[orig_patent_app_number] => 592098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184579 [patent_doc_number] => 06093540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor' [patent_app_type] => 1 [patent_app_number] => 8/573186 [patent_app_country] => US [patent_app_date] => 1995-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4828 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093540.pdf [firstpage_image] =>[orig_patent_app_number] => 573186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048236 [patent_doc_number] => 05968894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Verotoxin pharmaceutical compositions and medical treatments therewith' [patent_app_type] => 1 [patent_app_number] => 8/563394 [patent_app_country] => US [patent_app_date] => 1995-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 10822 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968894.pdf [firstpage_image] =>[orig_patent_app_number] => 563394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236506 [patent_doc_number] => 06090631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Methods and compositions for screening for presynaptic calcium channel blockers' [patent_app_type] => 1 [patent_app_number] => 8/558135 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 14843 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090631.pdf [firstpage_image] =>[orig_patent_app_number] => 558135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235504 [patent_doc_number] => 06090570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state' [patent_app_type] => 1 [patent_app_number] => 8/554416 [patent_app_country] => US [patent_app_date] => 1995-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8207 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090570.pdf [firstpage_image] =>[orig_patent_app_number] => 554416 [rel_patent_id] =>[rel_patent_doc_number] =>)